No Major Congenital Risk Posed for Using Non-Steroidal Anti-Inflammatory Drugs in the First Trimester of Pregnancy
No Major Congenital Risk Posed for Using Non-Steroidal Anti-Inflammatory Drugs in the First Trimester of Pregnancy
November 12, 2012
Medical Research, Press Releases
BEER-SHEVA, ISRAEL, November 12, 2012 – Researchers at Ben-Gurion University of the Negev (BGU) report in a new study that exposure to non-steroidal anti-inflammatory drugs, which include ibuprofen, during the first trimester of pregnancy does not increase the risk for major congenital malformations.
The population-based retrospective cohort study, just published in The Journal of Rheumatology, included nearly 110,000 pregnancies.
Non-steroidal anti-inflammatory drugs (NSAID) are among the most common medicines used by pregnant women.
Use of ibuprofen in first trimester pregnancies increased sharply between 1998 and 2009; it was the most commonly dispensed NSAID during those years.
“The study investigated exposure to NSAID in the first trimester in a large cohort of infants and fetuses. Despite the steady increased use of NSAID among women in the first trimester of pregnancy there was no association found between groups of malformations according to organ systems,” says BGU researcher Amalia Levy M.P.H., Ph.D., Department of Epidemiology and Health Services Evaluation, Faculty of Health Sciences.
ABOUT AMERICANS FOR BEN-GURION UNIVERSITY
By supporting a world-class academic institution that not only nurtures the Negev, but also shares its expertise locally and globally, Americans for Ben-Gurion University engages a community of Americans who are committed to improving the world. David Ben-Gurion envisioned that Israel’s future would be forged in the Negev. The cutting-edge research carried out at Ben-Gurion University drives that vision by sustaining a desert Silicon Valley, with the “Stanford of the Negev” at its center. The Americans for Ben-Gurion University movement supports a 21st century unifying vision for Israel by rallying around BGU’s remarkable work and role as an apolitical beacon of light in the Negev desert.
About Ben-Gurion University of the Negev
Ben-Gurion University of the Negev embraces the endless potential we have as individuals and as a commonality to adapt and to thrive in changing environments. Inspired by our location in the desert, we aim to discover, to create, and to develop solutions to dynamic challenges, to pose questions that have yet to be asked, and to push beyond the boundaries of the commonly accepted and possible.
We are proud to be a central force for inclusion, diversity and innovation in Israel, and we strive to extend the Negev’s potential and our entrepreneurial spirit throughout the world. For example, the multi-disciplinary School for Sustainability and Climate Change at BGU leverages over 50 years of expertise on living and thriving in the desert into scalable solutions for people everywhere.
BGU at a glance:
20,000 students | 800 senior faculty | 3 campuses | 6 faculties: humanities & social sciences, health sciences, engineering sciences, natural sciences, business & management, and desert research.
For all press inquiries, please contact:
James Fattal, J Cubed Communications
516.289.1496
Stories Like This
